J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market Posted on October 22, 2022 By Charlielikes Stock Market
Alkermes holder Sarissa Capital says it may look to increase its stake Posted on October 7, 2022 By Charlielikes Stock Market